Status:

COMPLETED

Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.

Lead Sponsor:

rabab ahmed mohamed

Collaborating Sponsors:

Cairo University

Conditions:

Contrast-induced Nephropathy

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

This prospective study is intended to evaluate if carvedilol has any potential protective effect over atorvastatin on the development of contrast-induced nephropathy (CIN) following cardiac catheteriz...

Detailed Description

This study enrolled 150 patients planned for CC, and randomly assigned for one of the three groups. Group (A)include 49 patients who received two atorvastatin dose 80 mg 12 hours before CC and 40 mg j...

Eligibility Criteria

Inclusion

  • Patients aged between 18 and 70 years.
  • Serum creatinine ≤ 1.5 mg/dL.
  • Using a moderate dose of atorvastatin (40 mg or equivalent dose of other statins).
  • Moderate to high-risk for CIN.

Exclusion

  • Patients suffering from ST-segment elevation myocardial infarction (STEMI)
  • Patients need for immediate cardiac catheterization
  • Elevated liver enzymes (Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) three times the upper limit of normal).
  • Active infection.
  • Any contraindication to carvedilol, or atorvastatin.
  • Patients on regular use of vitamins, minerals.
  • Using medication with antioxidant properties e.g., beta-carotene, vitamin E, vitamin C, selenium, theophylline or N-acetyl cysteine 7 days prior to CC.
  • Hemodynamically unstable patients (defined as abnormal or unstable blood pressure, especially hypotension (blood pressure less than 90/60 mm Hg).
  • Patients who required dialysis.
  • Pregnancy.
  • Using of carvedilol in the past three months.
  • Using a nephrotoxic agent in the past 48 hours or exposure to a contrast agent in the past 7 days prior to cardiac catheterization.

Key Trial Info

Start Date :

February 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 15 2017

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT03867994

Start Date

February 1 2016

End Date

May 15 2017

Last Update

March 12 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.